PI Industries reported a 19% YoY decline in Agchem Exports for Q4 FY26 due to global industry contraction and customer delivery schedules.
Domestic revenue softened 9% YoY despite 3% volume growth, impacted by market inventory, pricing pressure, and reduced crop acreages.
Pharma business revenue grew 23% YoY in Q4, contributing 8% to exports, while EBITDA margin met guidance at 25% for FY26.
The Board approved a final dividend of Rs 10 per share, bringing the total FY25-26 dividend to Rs 15 per share.